Officials are lauding the country's response to the latest outbreak of the deadly virus, but some say delays meant missed opportunities to test potential vaccines.
Officials are lauding the country's response to the latest outbreak of the deadly virus, but some say delays meant missed opportunities to test potential vaccines.
Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according to results.
The approval for export comes after an application was submitted to the Drugs Controller General of India by Prakash Kumar Singh, Director, Serum Institute of India, on November 30.